Patchseq Data of T1D Donor Islets vs ND Matched Controls
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA1126733 | ENA |
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| SRR29494200_1.fastq.gz | Fastqsanger.gz | |||
| SRR29494200_2.fastq.gz | Fastqsanger.gz | |||
| SRR29494300_1.fastq.gz | Fastqsanger.gz | |||
| SRR29494300_2.fastq.gz | Fastqsanger.gz | |||
| SRR29494400_1.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 5 of 1916 |
Similar Datasets
Project description:Will be updated closer to manuscript finalization. Patchseq allows for combined electrical and transcriptomic data to be obtained at single cell resolution. Here we performed patchseq on islet cells from human donors
2024-06-25 | GSE270484 | GEO
Project description:Type 1 Diabetes (T1D) is characterized by autoimmune-mediated destruction of insulin-producing beta-cells. Recent research has focused on the role of the innate immune system in initiating this process. To investigate this further, we used m6A-profiling of human islets from non-diabetic individuals and the human beta-cell line EndoC-bH1 treated with PBS or interleukin 1 beta and interferon alpha, as well as established T1D patients. Our findings reveal that N6-Methyladenosine (m6A) is a mechanism that helps protect beta-cells by accelerating the decay of mRNA from the 2'-5'-oligoadenylate synthetase (OAS) genes, which controls the antiviral innate immune response at the onset of T1D. These results provide insight into the adaptive safeguarding mechanisms of beta-cells and the role of m6A in T1D development, highlighting potential targets for therapeutic interventions.
2024-01-01 | GSE228267 | GEO
Project description:Our current understanding of the pathogenesis of T1D arose in large part from studies using the non-obese diabetic (NOD) mouse model of type 1 diabetes (T1D). Of concern, therapeutic interventions shown to significantly dampen or even reverse disease in mouse models have not successfully translated into interventions in human T1D. The present study addresses this disconnect in research translation by directly analyzing human donor islets from individuals with T1D, aiming to provide insight into disease mechanisms and identify potential target pathways for therapeutic intervention. We obtained human islets from a young individual with short-duration T1D, an older individual with long-duration T1D and three non-diabetic donors, and performed unbiased functional genomic analysis by high depth RNA sequencing on these unique cases. This analysis identified several inflammatory pathways upregulated in short-duration disease, which surprisingly included many components of innate immunity. Subsequent manipulation of one of these pathways/factors in NOD mice resulted in a significant reduction in diabetes progression when inhibition occurred early in disease progression. Taken together our data demonstrates that the direct analysis of human islets is essential for identifying relevant and promising novel targets for translation into effective therapeutic interventions for human T1D.
2018-07-30 | GSE102371 | GEO
Project description:m6A RIP-seq for Cytokine-treated Islets and Beta-cells or T1D Islets
| PRJNA949172 | ENA
Project description:The β-cell plays a central role in the pathogenesis of T1D by neoantigen formation due to the generation of post-translational modifications, such as deamidation, being potential triggers for breaking immune tolerance. We report the detection by LC-MS/MS of 16 novel Gln and 27 novel Asn deamidations in 14 T1D-related proteins in inflammatory cytokine-stressed human islets of Langerhans. T-cell clones responsive against two Gln and three Asn deamidated peptides could be isolated from peripheral blood of T1D subjects. Ex vivo tetramer assays indicated higher T-cell frequencies in subjects with T1D compared to control subjects and a positive correlation between frequencies and insulin antibody levels at diagnosis and duration of disease for one Gln and two Asn deamidated peptides. These results highlight that inflammatory cytokine-exposed human islets are prone to both enzymatic and biochemical deamidation and suggest that both Gln and Asn deamidated peptides can promote the activation of CD4+ T cells in individuals with T1D. These findings add to the growing list of evidence that post-translational modifications undermine tolerance in T1D and may open the road for the development of new diagnostic and therapeutic applications for people living with T1D.
2025-05-06 | PXD038758 | Pride
Project description:RNA-seq of primary islets in HFD_DMSO，HFD_CGP and ND mice
| PRJNA745471 | ENA
Project description:We investigated the underlying molecular mechanism of CGP 57380's effects in type 2 diabetes by comparing gene expression of whole primary islets isolated from HFD_DMSO,HFD_CGP and ND mice by RNA sequencing.C57BL/6 mice were fed an HFD for 4 months and then oral gavage DMSO and CGP 57380 for about 1 month separately to studied gene-expression differences resulting in HFD-induced hyperinsulinemia and metabolic abnormities.At the same time ,explore the therapeutic effect of CGP 57380 on type 2 diabetes,and the changes in the signal pathways in it.Gene set-enrichment ananlysis was performed using Kyoto Encyclopedia of Genomes algorithms and MSigDB software.The most enriched pathways were linked to pathyways associated with PI3K-Akt signaling pathway, pancreatic secretion and NF-kappa B signaling pathway.
2021-07-18 | GSE179893 | GEO
Project description:Type 2 diabetes is associated with defective insulin secretion and reduced β-cell mass. Available treatments provide a temporary reprieve, but secondary failure rates are high, making insulin supplementation necessary. Reversibility of b-cell failure is a key translational question. Here, we reverse-engineered and interrogated pancreatic islet-specific regulatory networks to discover T2D-specific subpopulations characterized by metabolic-inflexibility and endocrine-progenitor/stem cell features. Single-cell gain- and loss-of-function and glucose-induced Ca++ flux analyses of top candidate MR in islet cells validated transcription factor BACH2 and associated epigenetic effectors as a key driver of T2D cell states. BACH2 knockout in T2D islets reversed cellular features of the disease, restoring a non-diabetic phenotype. BACH2-immunoreactive islet cells increased ~4-fold in diabetic patients, confirming the algorithmic prediction of clinically relevant subpopulations. Treatment with a BACH inhibitor lowered glycemia and increased plasma insulin levels in diabetic mice, and restored insulin secretion in diabetic mice and human islets. The findings suggest that T2D-specific populations of failing b-cells can be reversed and indicate pathways for pharmacological intervention, including via BACH2 inhibition.
2021-11-11 | GSE136887 | GEO
Project description:To unravel genes and molecular pathways involved in the pathogenesis of type 1 diabetes (T1D), we performed genome-wide gene expression profiling of prospective venous blood samples from children developing T1D-associated autoantibodies or progressing towards clinical diagnosis. 357 peripheral blood RNA samples from 10 autoantibody-positive children (Case) and their matched controls (Control) or alternatively 18 prediabetic children (T1DCase) and their matched controls (T1DControl) were analyzed with Affymetrix U219 gene array, in order to study the gene expression changes occuring during the pathogenesis of Type 1 diabetes (T1D). Each case child (positive for T1D-specific autoantibodies) was matched with a persistently autoantibody-negative control child, with the same HLA-DQB1 risk category, gender, and place and date of birth. Seroconversion is determined as the first detection of T1D-specific autoantibody/autoantibodies (ICA titre >4 JDFU, IAA >3.47 RU, GADA >5.4 RU, IA-2A >0.43 RU, ZnT8A >0.61 RU). Two control children were selected for T1D cases 3, 5, 13 and 17. Case5 & T1DCase15 and Case7 & T1DCase3 share the same matched control. Sample T1DControl7_4 was excluded from the final analysis as an outlier, resulting in 356 total Samples listed below.
2014-02-20 | E-GEOD-43488 | biostudies-arrayexpress